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Summary: A rapid ELISA test for detection, characterization and quantification of human paraproteins was devel-
oped. The proposed method is a sandwich ELISA, where the capture antibody is specific for a given heavy chain
(γ, α or μ) and the labelled antibody is specific either for κ or for λ light chain. Both standard and patient sera are
tested with all six possible antibody combinations. Each paraprotein produces a significant increase in titre (as
compared with standard) only when tested with the relevant pair of antibodies. This enables the determination of
the isotype and light chain type of the paraprotein and the evaluation of its relative quantity in patient serum. The
accuracy of the assay (relative deviation) varies from 0.04 for γλ to 0.19 for ακ. The cut-off values for each type
of polyclonal immunoglobulin were determined with 200 healthy donor sera. 103 patient sera were analysed. ELISA
data are in good agreement with M-component and other clinical data.
Introduction
Detection and quantification of monoclonal paraproteins
in patient sera are diagnostically important when a ma-
lignancy of the lymphoid system is suspected. Currently,
the following methods are employed to detect parapro-
teins:
serum protein electrophoresis (1),
serum immunoelectrophoresis (2),
two-dimensional electrophoresis (3—5),
high-resolution agarose gel electrophoresis (6),
immunoblotting, immunofixation (4, 7—9).
The expression of peripheral blood B-cell surface or in-
tracellular immunoglobulins measured by an immuno-
fluorescence technique is also used to identify the malig-
nant B-cell clone (10, 11). The classification of parapro-
teins according to their heavy and light chain requires
immunoelectrophoresis, immunoblotting, immunofixa-
tion or immunofluorescence, whereas these methods are
not very useful for quantification. The amount of para-
protein in the serum is usually calculated from the rela-
tion of paraprotein in serum electrophoresis and total
serum protein concentration. Most of /these methods,
though well established and validated, are laborious and
time-consuming. In this paper we present a simple and
rapid ELISA test, that enables detection of the myeloma
product, identification of its class, light chain type and
quantity in patient serum.
Materials and Methods
Monoclonal antibodies
All monoclonal antibodies used in this study were produced, puri-
fied and characterised in our laboratory (12,13). Hybridomas were
established by the K hler-Milstein technique (14). BALB/c mice
were immunised with mixed human immunoglobulins, isolated
IgG Fc fragments or purified IgA, and the spleen cells were fused
with myeloma cells. Indirect ELISA was used to select positive
clones.
Monoclonal antibodies were purified from ascites by ammonium
sulphate precipitation and affinity chromatography on protein A
Sepharose (15). The purity of antibody preparations, tested in SDS-
polyacrylamide gel, was over 99%. Horseradish peroxidase was
linked to antibodies by a periodate method (16). Anti-γ and anti-a
monoclonal antibodies reacted with all subclasses of polyclonal
and monoclonal IgG and IgA.
Sera
Blood samples were obtained by venipuncture and sera were stored
at —20 °C. Standard pooled serum was collected from 50 healthy
donors. The immunoglobulin concentrations in standard pooled se-
rum were determined both by radial immunodiffusion (17) and
ELISA (18). IgG, IgA and IgM concentrations were 14.7 g/1, 2.07
g/1 and 1.24 g/1 respectively. No paraproteins were detected in the
pooled standard by agarose gel scanning (1). Standard sera did not
possess antibodies against cytomegalovirus, hepatitis Β and C and
HIV type I, as established with Abbott's antibody kits.
Test sera samples were collected from patients of the Haematology
Department of Vilnius University Hospital. A total of 103 patient
sera was tested.
Enzyme linked immunosorbent assay
Dynatech Immunolon 96-well plates were used to perform ELISA
tests. Purified monoclonal antibodies (5 mg/1 in 50 mmol/1 Na
phosphate buffer pH 6.0) were pipetted into the plates, 0.1 ml per
well, and incubated overnight at 4 °C. Wells were further blocked
with 10 g/1 albumin in phosphate-buffered saline (0.15 ml/well,
30 min, room temperature) and washed (3 times with phosphate-
buffered saline). Eight serial 3-fold dilutions of serum samples,
both standard and patient, were prepared in phosphate-buffered sa-
line and 0.1 ml of each dilution was applied to the wells. The
starting serum dilutions were as follows: 1 :30 000 for anti-γ—
anti-κ sandwich, 1 : 4000 for anti-γ—anti-λ sandwich and I : 1000
for the other four monoclonal antibodies combination. To achieve
acceptable precision the 1 : 30 000 and 1 : 4000 dilutions were pre-
pared in two steps, using 1 : 1000 as an intermediate dilution. Sera
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were incubated 60 min at room temperature, plates were washed
(three times in phosphate-buffered saiine with 0.5 g/1 Tween 20)
and 0.1 ml of appropriate horseradish peroxidase conjugates (anti-
K or anti-λ I : 1000 in phosphate-buffered saline-Tween 20) was
added. Plates were incubated for 30 min at room temperature and
washed (10 times, phosphate-buffered saline-Tween 20). Bound
horseradish peroxidase was detected with o-phenylenediamine (0.1
ml/well, 0.5 g/1 o-phenylenediamine and 17.6 mmol/I H2O2 in 25
mmol/1 CH3COONa, pH 5.5). All colour reactions were stopped
with 2 mol/1 H2SO4 (0.05 ml/well) and the absorbance was mea-
sured in a Titertek Multiscan plate reader at 492 nm.
Evaluat ion of ELISA data
The quantity of immunoglobulin population is calculated in the
following way: we have pooled healthy donors sera used as a con-
trol standard serum. The quantity of each Ig type (γκ, γλ, ακ, αλ,
μκ or μλ) is set 1 arbitrary units. Tested sera are compared to this
standard and the quantity of each Ig population (γκ, γλ, ακ, αλ,
μκ or μλ) in patients sera were calculated according the formula:
Quantity of Ig population = (T50 of Ps/T50 of Ss)
(arb. units),
where




If the particular Ig type for example γκ, in the individually tested
serum is underrepresented, as compared with the standard, then we
get a quantity value < 1 arb. unit. On the contrary, if this given Ig
type is increased, we would have a quantity value > 1 arb. unit.
Even in healthy donors sera the quantity values vary significantly.
In patients with paraproteinaemia, where increase in particular Ig
type is enormously large, the calculated quantity values can reach
100 arb. units or even more.
Assay accuracy and reproducibility
To determine the assay accuracy sera were tested in five replicates
in the same ELISA plate. The test accuracy was expressed as the
relative standard deviation (CV, %) of absorbances within experi-
ments. The reproducibility of the test was evaluated as between-
run relative deviation of the arbitrary units of the same serum,
tested in five different experiments. The ELISA test was performed
and the arbitrary units calculated as described above.
Determination of other diagnostic properties
The serum M-component was detected by agarose gel scanning
(1). Total serum protein was quantified according to Lowry (19).
Bone marrow punctate cell slides were prepared, stained with
Giesma (2) and examined microscopically. Total cells, plasma cells
and lymphocytes were counted and their fraction calculated.
Tab. 1 Assay accuracy and reproducibility






































To determine the cut-off values for identification of mo-
noclonal paraprotein component in the patient, values of
arbitrary units for each type of immunoglobulin were cal-
culated for sera from 200 healthy donors. The cut-off val-
ues (mean arbitrary units plus 3 Χ σ) determined for each
pair of monoclonal antibodies are presented in table 2.












































Sera with values of arbitrary units exceeding the cut-off
value in one or two combinations of monoclonal anti-
bodies were considered to be paraprotein-positive or
double positive (possessing two paraproteins). The sand-
wich type with an increased value of arbitrary units indi-
cated the heavy chain class and light chain type of the
detected paraprotein(s). For example, if an increase of
arbitrary unit values was determined using anti-γ capture
Results
The present approach is based on the consideration that
all immunoglobulins, detected in sandwich anti-γ-anti-
K, belong to the γκ immunoglobulin population; the
anti-γ-anti-λ monoclonal antibodies pair detects all γλ
immunoglobulins in tested sera, and so on. For each pair
of monoclonal antibodies the end-point of the serum tit-
ration curve was supposed to reflect the arbitrary unit of
the respective immunoglobulin type (γκ, γλ, ακ, αλ, μκ
or μλ). The assay accuracy and reproducibility charac-
teristics were studied and the data are documented in
the table 1.
Tab. 3 Paraprotein detection in patient sera by monoclonal anti-
body-based sandwich ELISA
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Fig. 1 The detection of monoclonal immunoglobulins using sand-
wich ELISA. ELISA plates were coated with heavy chain specific
monoclonal antibodies. The bound immunoglobulins were quanti-
tated with light chain specific monoclonal antibodies conjugated
with horseradish peroxidase.
and anti-κ labelled antibodies, the paraprotein was clas-
sified as γκ. The detection of some monoclonal Ig is
shown in figure 1.
Sera of 103 patients, with B- and T-cell malignancies,
other haematological diseases and autoimmune diseases
were tested in the proposed ELISA system. The results
are summarised iii table 3.
Our data on detection and quantification of paraproteins
were compared with other significant diagnostic quanti-
ties. These included: M component and total protein
quantity in patient sera, percent of plasma cells and lym-
phocytes in bone marrow punctate. This was done for
all patients, and some of the data together with the final
disease diagnosis are presented in table 4. These data
demonstrate a good agreement of the ELISA results with
the other properties studied.
Discussion
Detection and quantification of monoclonal components,
associated with certain B-cell malignancies is a well
Π Immunoglobulins of healthy donors
H immunoglobulins of patients with B-cell malignancies
established routine procedure in clinical laboratories.
Nevertheless these validated techniques are laborious
and time-consuming. A rapid and simple ELISA test is
an improvement in the clinical laboratory.
This paper presents a monoclonal antibody-based sand-
wich ELISA that enables the detection, classification
and quantification of paraproteins in a single test. The
rational of the method is as follows: immunoglobulins
of a given class (γ, α or μ) are captured by immobilised
class-specific antibodies and visualised with enzyme-
linked antibodies specific for the κ or λ light chain. Pa-
tient sera are tested in all six possible antibody combina-
tions and compared with standard pooled healthy donor
serum. The increase in certain immunoglobi in popula-
tion (γκ, γλ, ακ, αλ, μκ or μλ) can be calculated. The
absolute quantitation of monoclonal components cannot
be achieved by the proposed ELISA, but this is not al-
ways necessary for the clinical follow up of myeloma
patients. It can be easily judged from the routine labora-
tory values for total serum protein concentration and se-
rum protein electrophoresis. The diagnostic value of the
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method is to measure relative changes in an individual
patient. From this point of view both the methods and
the mode of evaluation seem to be informative.
Clinical data for all patients included in this study were
collected and correlated with the presence and relative
quantities of paraprotein in sera. The preliminary results
confirm the consensus of ELISA and clinical data.
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